This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mathis, A. M.
Right arrow Articles by Hall, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mathis, A. M.
Right arrow Articles by Hall, J. E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, June 2006, p. 2185-2191, Vol. 50, No. 6
0066-4804/06/$08.00+0     doi:10.1128/AAC.00192-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Accumulation and Intracellular Distribution of Antitrypanosomal Diamidine Compounds DB75 and DB820 in African Trypanosomes

Amanda M. Mathis,1 Jacqueline L. Holman,1,{dagger} Lisa M. Sturk,1,2,{ddagger} Mohamed A. Ismail,3 David W. Boykin,3 Richard R. Tidwell,2 and James Edwin Hall1,2*

Division of Molecular Pharmaceutics, School of Pharmacy, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina,1 Department of Pathology and Laboratory Medicine, UNC School of Medicine, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina,2 Department of Chemistry, Georgia State University, Atlanta, Georgia3

Received 13 February 2006/ Returned for modification 3 March 2006/ Accepted 1 April 2006

The aromatic diamidine pentamidine has long been used to treat early-stage human African trypanosomiasis (HAT). Two analogs of pentamidine, DB75 and DB820, have been shown to be more potent and less toxic than pentamidine in murine models of trypanosomiasis. The diphenyl furan diamidine, DB75, is the active metabolite of the prodrug DB289, which is currently in phase III clinical trials as a new orally active candidate drug to treat first-stage HAT. The new aza analog, DB820, is the active diamidine of the prodrug DB844, currently undergoing preclinical evaluation as a new candidate to treat HAT of the central nervous system. The exact mechanisms of antitrypanosomal activity of aromatic dications remain poorly understood, with multiple mechanisms hypothesized. Pentamidine is known to be actively transported into trypanosomes and binds to DNA within the nucleus and kinetoplast. A long-hypothesized mechanism of action has been that DNA binding ultimately leads to interference with DNA-associated enzymes. Both DB75 and DB820 are intensely fluorescent, which provides an important tool for determining the kinetics of accumulation and intracellular distribution in trypanosomes. We show in the current study that DB75 and DB820 rapidly accumulate and strongly concentrate within trypanosomes, with intracellular concentrations over 15,000-fold higher than mouse plasma concentrations. Both compounds initially accumulate in the DNA-containing nucleus and kinetoplast, but at later time points, they concentrate in non-DNA-containing cytoplasmic organelles. Analyses of the kinetics of uptake and intracellular distribution are necessary to begin to define antitrypanosomal mechanisms of action of DB75, DB820, and other aromatic diamidines.


* Corresponding author. Mailing address: 3312 Kerr Hall, CB#7360, Molecular Pharmaceutics, UNC School of Pharmacy, Chapel Hill, NC 27599. Phone: (919) 966-6297. Fax: (919) 966-0197. E-mail: je_hall{at}unc.edu.

{dagger} Present address: 937 Mary Ellen Jones Bldg., UNC School of Medicine, Chapel Hill, NC 27599.

{ddagger} Present address: Shire Human Genetic Therapies, 700 Main St., Cambridge, MA 02139.


Antimicrobial Agents and Chemotherapy, June 2006, p. 2185-2191, Vol. 50, No. 6
0066-4804/06/$08.00+0     doi:10.1128/AAC.00192-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Wenzler, T., Boykin, D. W., Ismail, M. A., Hall, J. E., Tidwell, R. R., Brun, R. (2009). New Treatment Option for Second-Stage African Sleeping Sickness: In Vitro and In Vivo Efficacy of Aza Analogs of DB289. Antimicrob. Agents Chemother. 53: 4185-4192 [Abstract] [Full Text]  
  • da Silva, C. F., Batista, M. M., Batista, D. d. G. J., de Souza, E. M., da Silva, P. B., de Oliveira, G. M., Meuser, A. S., Shareef, A.-R., Boykin, D. W., Soeiro, M. d. N. C. (2008). In Vitro and In Vivo Studies of the Trypanocidal Activity of a Diarylthiophene Diamidine against Trypanosoma cruzi. Antimicrob. Agents Chemother. 52: 3307-3314 [Abstract] [Full Text]  
  • Lanteri, C. A., Tidwell, R. R., Meshnick, S. R. (2008). The Mitochondrion Is a Site of Trypanocidal Action of the Aromatic Diamidine DB75 in Bloodstream Forms of Trypanosoma brucei. Antimicrob. Agents Chemother. 52: 875-882 [Abstract] [Full Text]  
  • Silva, C. F., Meuser, M. B., De Souza, E. M., Meirelles, M. N. L., Stephens, C. E., Som, P., Boykin, D. W., Soeiro, M. N. C. (2007). Cellular Effects of Reversed Amidines on Trypanosoma cruzi. Antimicrob. Agents Chemother. 51: 3803-3809 [Abstract] [Full Text]  
  • Mathis, A. M., Bridges, A. S., Ismail, M. A., Kumar, A., Francesconi, I., Anbazhagan, M., Hu, Q., Tanious, F. A., Wenzler, T., Saulter, J., Wilson, W. D., Brun, R., Boykin, D. W., Tidwell, R. R., Hall, J. E. (2007). Diphenyl Furans and Aza Analogs: Effects of Structural Modification on In Vitro Activity, DNA Binding, and Accumulation and Distribution in Trypanosomes. Antimicrob. Agents Chemother. 51: 2801-2810 [Abstract] [Full Text]  
  • Lanteri, C. A., Stewart, M. L., Brock, J. M., Alibu, V. P., Meshnick, S. R., Tidwell, R. R., Barrett, M. P. (2006). Roles for the Trypanosoma brucei P2 Transporter in DB75 Uptake and Resistance. Mol. Pharmacol. 70: 1585-1592 [Abstract] [Full Text]